Standout Papers

Physiological Parameters in Laboratory Animals and Humans 1993 2026 2004 2015 2.4k
  1. Physiological Parameters in Laboratory Animals and Humans (1993)
    Brian E. Davies, Tim Morris Pharmaceutical Research

Citation Impact

Citing Papers

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Reconstituting Organ-Level Lung Functions on a Chip
2010 StandoutScience
Pharmacokinetics and Pharmacodynamics of Edivoxetine (LY2216684), a Norepinephrine Reuptake Inhibitor, in Pediatric Patients with Attention-Deficit/ Hyperactivity Disorder
2012
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA
2021 StandoutNobel
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Prognosis and prognostic research: what, why, and how?
2009
Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice
2004
Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review
2006
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
2018 Standout
Rheumatoid arthritis
2016 Standout
Should Rituximab be Considered as the First-Choice Treatment for Severe Autoimmune Rheumatic Diseases?
2007
Clinical Pharmacokinetics of Topotecan
1996
Scaling and systems biology for integrating multiple organs-on-a-chip
2013
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac
2013
Symposium on ‘Geographical and geological influences on nutrition’ Factors controlling the distribution of selenium in the environment and their impact on health and nutrition
2009
Technical Challenges in Using Human Induced Pluripotent Stem Cells to Model Disease
2009
Ectopic Lymphoid Structures Support Ongoing Production of Class-Switched Autoantibodies in Rheumatoid Synovium
2009
Cancer stem cells revisited
2017 Standout
Selenium and human health
2012 Standout
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
The journey of a drug-carrier in the body: An anatomo-physiological perspective
2011
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Cancer nanotechnology: opportunities and challenges
2005 Standout
Multiple sclerosis
2008 Standout
Pharmacokinetics ofS-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro- 3-trifluoromethyl-phenyl)-propionamide in rats, a non-steroidal selective androgen receptor modulator
2004
A micro cell culture analog (µCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs
2009
Clinical Pharmacokinetic, Pharmacodynamic, and Drug–Drug Interaction Profile of Canagliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor
2015
Nephrogenic Systemic Fibrosis
2009
Dihydroindenoisoquinolines function as prodrugs of indenoisoquinolines
2005
Signalling pathways of the TNF superfamily: a double-edged sword
2003 Standout
Microfluidic organs-on-chips
2014 Standout
Integration ofin silicoandin vitroplatforms for pharmacokinetic–pharmacodynamic modeling
2010
Lanthanide luminescence for functional materials and bio-sciences
2009 Standout
A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody–associated vasculitis
2009
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Integrated Nanoparticle–Biomolecule Hybrid Systems: Synthesis, Properties, and Applications
2004 Standout
Contrast Agents for MR Imaging of the Liver
2001
Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies
2007
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
2020 Standout
Rituximab
2007
Bridging In Vitro and In Vivo Metabolism and Transport of Faldaprevir in Human Using a Novel Cocultured Human Hepatocyte System, HepatoPac
2013
A microfluidic device for a pharmacokinetic–pharmacodynamic (PK–PD) model on a chip
2010
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
Safety of gadolinium contrast angiography in patients with chronic renal insufficiency
2003
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation
1997
Zinc in plants
2007 Standout
New developments for antibody-drug conjugate-based therapeutic approaches
2016
Brain uptake of thiamine-coated nanoparticles
2003
Screening, Diagnosis, and Treatment of Cancer in Long-Term Dialysis Patients
2007
Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan
2000
Chronic Kidney Disease
2016 Standout
Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Agents
2011
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Estimates of ambient background concentrations of trace metals in soils for risk assessment
2007
Characterization of a gastrointestinal tract microscale cell culture analog used to predict drug toxicity
2009
Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs
2011
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
2017 StandoutNature
An Official American Thoracic Society Workshop Report: Features and Measurements of Experimental Acute Lung Injury in Animals
2011 Standout
Mouse Models of Acute Respiratory Distress Syndrome
2015
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
The effects of biocidal treatments on metabolism in soil—II. Gamma irradiation, autoclaving, air-drying and fumigation
1976
Chronic Kidney Disease Diagnosis and Management
2019 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Carbon quantum dots and their applications
2014 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors
2009
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
2009 Standout
Arsenite transport by mammalian aquaglyceroporins AQP7 and AQP9
2002 StandoutNobel
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Deep-tissue anatomical imaging of mice using carbon nanotube fluorophores in the second near-infrared window
2011
Modeling hepatitis C virus infection using human induced pluripotent stem cells
2012 StandoutNobel
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
An extraction method for measuring soil microbial biomass C
1987 Standout
Inorganic arsenic: a need and an opportunity to improve risk assessment.
1997
Cyclodextrin Drug Carrier Systems
1998 Standout
MRI Safety Update 2008: Part 1, MRI Contrast Agents and Nephrogenic Systemic Fibrosis
2008
Capacity limits of asialoglycoprotein receptor-mediated liver targeting
2017
Efficient Tumor Eradication at Ultralow Drug Concentration via Externally Controlled and Boosted Metallic Iron Magnetoplasmonic Nanocapsules
2022
Soil Contamination in China: Current Status and Mitigation Strategies
2014 Standout
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
The immediate effect of burning and ash-fertilization
1984
Computational and Ultrastructural Toxicology of a Nanoparticle, Quantum Dot 705, in Mice
2008
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Preclinical Studies to Predict the Disposition of Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Humans: Characterization of in Vivo Efficacy, Pharmacokinetics, and Safety
2001
The influence of sediment recycling and basement composition on evolution of mudrock chemistry in the southwestern United States
1995 Standout
Neurons generated by direct conversion of fibroblasts reproduce synaptic phenotype caused by autism-associated neuroligin-3 mutation
2013 StandoutNobel
The role of soil organic matter in sustaining soil fertility
1994 StandoutNature
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout

Works of Brian E. Davies being referenced

Safety and Pharmacokinetic Profile of Gadobenate Dimeglumine in Subjects With Renal Impairment
1999
Physiological Parameters in Laboratory Animals and Humans
1993 Standout
Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency
2000
Airs, waters and places
1985
The Pharmacokinetics of Topotecan and Its Carboxylate Form Following Separate Intravenous Administration to the Dog
1997
Interspecies Pharmacokinetics of a Novel Hematoregulatory Peptide (SK&F 107647) in Rats, Dogs, and Oncologic Patients
1996
Pharmacokinetics and pharmacodynamics of topotecan given on a daily-times-five schedule in phase II clinical trials using a limited-sampling procedure
1996
Population Pharmacokinetics of Rituximab (Anti‐CD20 Monoclonal Antibody) in Rheumatoid Arthritis Patients During a Phase II Clinical Trial
2005
Pharmacokinetics and pharmacodynamics of topotecan administered daily for 5 days every 3 weeks
1995
A Simple Centrifugation Method for obtaining Small Samples of Soil Solution
1963 Nature
A Statistical Comparison of pH Values of some English Soils after Measurement in both Water and 0.01M Calcium Chloride
1971
Rituximab Pharmacokinetics in Patients With Rheumatoid Arthritis: B‐Cell Levels Do Not Correlate With Clinical Response
2007
Guidelines for lead in soil. Proposal of the Society for Environmental Geochemistry and Health
1994
A graphical estimation of the normal lead content of some British soils
1983
Applied soil trace elements
1980
Radish as an indicator plant for derelict land: Uptake of zinc at toxic concentrations
1993
Rankless by CCL
2026